K
Ken Sugimoto
Researcher at Hamamatsu University School of Medicine
Publications - 322
Citations - 9388
Ken Sugimoto is an academic researcher from Hamamatsu University School of Medicine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 37, co-authored 281 publications receiving 6492 citations. Previous affiliations of Ken Sugimoto include Health Science University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Liang Kung Chen,Jean Woo,Prasert Assantachai,Tung Wai Auyeung,Ming Yueh Chou,Katsuya Iijima,Hak Chul Jang,Lin Kang,Miji Kim,Sunyoung Kim,Taro Kojima,Masafumi Kuzuya,Jenny S.W. Lee,Sang Yoon Lee,Wei Ju Lee,Yunhwan Lee,Chih Kuang Liang,Jae Young Lim,Wee Shiong Lim,Li Ning Peng,Ken Sugimoto,Tomoki Tanaka,Chang Won Won,Minoru Yamada,Teimei Zhang,Masahiro Akishita,Hidenori Arai +26 more
TL;DR: The Asian Working Group for Sarcopenia 2019 introduces "possible sarcopenia," defined by either low muscle strength or low physical performance only, specifically for use in primary health care or community-based health promotion, to enable earlier lifestyle interventions.
Journal ArticleDOI
Hypoadiponectinemia Is an Independent Risk Factor for Hypertension
Yoshio Iwashima,Tomohiro Katsuya,Kazuhiko Ishikawa,Noriyuki Ouchi,Mitsuru Ohishi,Ken Sugimoto,Yuxiao Fu,Masaharu Motone,Kouichi Yamamoto,Akiko Matsuo,Koji Ohashi,Shinji Kihara,Tohru Funahashi,Hiromi Rakugi,Yuji Matsuzawa,Toshio Ogihara +15 more
TL;DR: Hypoadiponectinemia is a marker for predisposition to hypertension in men and blood pressure was inversely associated with adiponectin concentration in normotensives regardless of insulin resistance.
Journal ArticleDOI
Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
Ada Congrains,Kei Kamide,Ryousuke Oguro,Osamu Yasuda,Keishi Miyata,Eiichiro Yamamoto,Tatsuo Kawai,Hiroshi Kusunoki,Hiroko Yamamoto,Yasushi Takeya,Koichi Yamamoto,Miyuki Onishi,Ken Sugimoto,Tomohiro Katsuya,Nobuhisa Awata,Kazunori Ikebe,Yasuyuki Gondo,Yuichi Oike,Mitsuru Ohishi,Hiromi Rakugi +19 more
TL;DR: It is suggested that several CVD-associated SNPs in the 9p21 locus affect the expression of ANRIL, which, in turn modulate cell growth, possibly via CDKN2A/B regulation.
Journal ArticleDOI
Curcumin prevents and ameliorates trinitrobenzene sulfonic acid–induced colitis in mice
Ken Sugimoto,Hiroyuki Hanai,Kotaro Tozawa,Taiki Aoshi,Masato Uchijima,Toshi Nagata,Yukio Koide +6 more
TL;DR: Treatment of mice with curcumin prevented and improved both wasting and histopathologic signs of TNBS-induced colonic inflammation, suggesting thatCurcumin could be a potential therapeutic agent for the treatment of patients with inflammatory bowel disease.
Journal ArticleDOI
Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study.
Hiroyuki Hanai,Fumitoshi Watanabe,Ken Takeuchi,Takayuki Iida,Masami Yamada,Yasushi Iwaoka,Abby R. Saniabadi,Isao Matsushita,Yoshihiko Sato,Kotaro Tozawa,Hajime Arai,Takahisa Furuta,Ken Sugimoto,Ingvar Bjarnason +13 more
TL;DR: Reduction of circulating granulocyte and monocyte adsorptive apheresis results in alleviation of inflammation and promotes clinical remission in patients with severe active UC that has not responded to intensive corticosteroid treatment.